Literature DB >> 16760681

Systems for care of hypertension in the United States.

Lawrence R Krakoff1.   

Abstract

Control of hypertension in recent clinical trials varies from 48% to 65%. However, in community care of hypertension in the United States, estimates of control of hypertension are far lower. The United States has no single system of care; however, several care systems can be identified for comparison, such as the Department of Veterans Affairs, managed care organizations, and the Indian Health Service. This review compares control of hypertension in certain centers in these systems with that achieved in clinical trials and in the community at large. Certain components of care systems are assessed for their contribution to the control of hypertension. The author concludes that for community control of hypertension to approach that achieved in clinical trials, the use of physician extenders, together with reduced or minimal cost of medication, improved education of providers with feedback, and computerization of management systems will be needed. In addition, specific interventions targeted to medically underserved groups will be required.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760681      PMCID: PMC8109424          DOI: 10.1111/j.1076-7460.2006.05385.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  56 in total

Review 1.  Can we alter physician behavior by educational methods? Lessons learned from studies of the management and follow-up of hypertension.

Authors:  Karen Tu; Dave Davis
Journal:  J Contin Educ Health Prof       Date:  2002       Impact factor: 1.355

2.  Prescription drug coverage, health, and medication acquisition among seniors with one or more chronic conditions.

Authors:  J Elizabeth Jackson; Mark P Doescher; Barry G Saver; Paul Fishman
Journal:  Med Care       Date:  2004-11       Impact factor: 2.983

3.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  How acceptable are financial incentives and written feedback for improving hypertension control? Perspectives from physicians, clinic administrators, and patients.

Authors:  Sharon J Rolnick; Karen L Margolis; Kristine K Fortman; Michael V Maciosek; Richard H Grimm
Journal:  Am J Manag Care       Date:  2002-05       Impact factor: 2.229

5.  Home monitoring service improves mean arterial pressure in patients with essential hypertension. A randomized, controlled trial.

Authors:  M A Rogers; D Small; D A Buchan; C A Butch; C M Stewart; B E Krenzer; H L Husovsky
Journal:  Ann Intern Med       Date:  2001-06-05       Impact factor: 25.391

6.  Hypertension treatment patterns in American Indians: the strong heart study.

Authors:  J A Hayslett; J E Eichner; J L Yeh; W Wang; J Henderson; R B Devereux; T K Welty; R R Fabsitz; B V Howard; E T Lee
Journal:  Am J Hypertens       Date:  2001-09       Impact factor: 2.689

7.  Hypertension control: how well are we doing?

Authors:  Ann M Borzecki; Ashley T Wong; Elaine C Hickey; Arlene S Ash; Dan R Berlowitz
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Assessment of factors influencing blood pressure control in a managed care population.

Authors:  Tanya M Romain; Rosalie P Patel; Andrea M Heaberlin; Barbara J Zarowitz
Journal:  Pharmacotherapy       Date:  2003-08       Impact factor: 4.705

10.  Improving hypertension care in a large group-model MCO.

Authors:  Paul Godley; Anh Nguyen; Krista Yokoyama; James Rohack; Billy Woodward; Tina Chiang
Journal:  Am J Health Syst Pharm       Date:  2003-03-15       Impact factor: 2.637

View more
  4 in total

1.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  Hypertension       Date:  2008-05-22       Impact factor: 10.190

2.  Therapeutic inertia and the Medicare crisis.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-09       Impact factor: 3.738

3.  Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination.

Authors:  Michael B Hovater; Edgar A Jaimes
Journal:  Integr Blood Press Control       Date:  2013-06-14

Review 4.  The risks and benefits of initial irbesartan/hydrochlorothiazide combination therapy in patients with severe hypertension.

Authors:  Pablo Lapuerta; Stanley Franklin
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-05       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.